Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$56.16 - $60.96 $616,805 - $669,523
-10,983 Reduced 33.31%
21,986 $1.33 Million
Q2 2024

Aug 13, 2024

BUY
$53.58 - $57.02 $773,641 - $823,311
14,439 Added 77.92%
32,969 $1.85 Million
Q1 2024

Apr 15, 2024

SELL
$42.56 - $59.82 $294,217 - $413,535
-6,913 Reduced 27.17%
18,530 $1.05 Million
Q4 2023

Jan 05, 2024

BUY
$32.18 - $46.57 $796,615 - $1.15 Million
24,755 Added 3598.11%
25,443 $1.14 Million
Q3 2023

Oct 18, 2023

BUY
$44.2 - $50.2 $30,409 - $34,537
688 New
688 $31,000
Q1 2023

Apr 12, 2023

SELL
$45.44 - $74.26 $450,492 - $736,213
-9,914 Reduced 32.43%
20,660 $1.36 Million
Q4 2022

Jan 17, 2023

BUY
$41.39 - $81.0 $538,649 - $1.05 Million
13,014 Added 74.11%
30,574 $1.38 Million
Q3 2022

Oct 07, 2022

BUY
$72.36 - $113.1 $217,803 - $340,431
3,010 Added 20.69%
17,560 $1.27 Million
Q2 2022

Jul 20, 2022

SELL
$87.2 - $114.05 $519,624 - $679,623
-5,959 Reduced 29.06%
14,550 $1.56 Million
Q1 2022

Apr 26, 2022

SELL
$94.19 - $124.49 $2.34 Million - $3.09 Million
-24,850 Reduced 54.79%
20,509 $2.27 Million
Q4 2021

Jan 13, 2022

BUY
$119.57 - $139.07 $2.75 Million - $3.2 Million
23,039 Added 103.22%
45,359 $5.81 Million
Q3 2021

Oct 18, 2021

SELL
$109.17 - $142.35 $614,954 - $801,857
-5,633 Reduced 20.15%
22,320 $2.97 Million
Q2 2021

Jul 30, 2021

BUY
$100.34 - $115.69 $339,149 - $391,032
3,380 Added 13.75%
27,953 $3.02 Million
Q1 2021

Apr 20, 2021

BUY
$101.51 - $125.27 $860,500 - $1.06 Million
8,477 Added 52.67%
24,573 $2.59 Million
Q4 2020

Jan 19, 2021

BUY
$85.88 - $105.36 $771,803 - $946,870
8,987 Added 126.42%
16,096 $1.68 Million
Q3 2020

Oct 30, 2020

BUY
$72.74 - $92.5 $196,107 - $249,380
2,696 Added 61.09%
7,109 $609,000
Q2 2020

Jul 15, 2020

BUY
$48.02 - $79.04 $74,623 - $122,828
1,554 Added 54.35%
4,413 $323,000
Q1 2020

Apr 14, 2020

BUY
$36.95 - $62.95 $46,852 - $79,820
1,268 Added 79.7%
2,859 $149,000
Q4 2019

Jan 22, 2020

BUY
$47.06 - $56.64 $74,872 - $90,114
1,591 New
1,591 $90,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.